Purmx Therapeutics

Hiroshima, Japan

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

Jun 2025

Grant

Alternative Medicine Biopharma Biotechnology Medical Pharmaceutical

Top Investors

Mitsubishi UFJ Capital UTEC - The University of Tokyo Edge Capital Partners Johnson & Johnson Innovation Osaka University Venture Capital Hiroshima Venture Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Purmx Therapeutics

Who are Purmx Therapeutics's investors?

Purmx Therapeutics's investors include Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, Johnson & Johnson Innovation, Osaka University Venture Capital, Hiroshima Venture Capital.

Where is Purmx Therapeutics headquartered?

Purmx Therapeutics is headquartered in Hiroshima, Japan.

What does Purmx Therapeutics do?

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

What stage is Purmx Therapeutics at?

Purmx Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2025.

MLA

"Purmx Therapeutics — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/purmx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Purmx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/purmx-therapeutics

Wikipedia (cite web)

{{cite web |title=Purmx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/purmx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2025.